Takatora Sawada

Ehime University

Papers

3

Total Citations

7

H-Index

2

About

Dr. Takatora Sawada is a pioneering urologic surgeon whose research focuses on advancing robotic-assisted surgery and optimizing treatment strategies for prostate and renal cancers. His most impactful work challenges established practices: a landmark 2025 study with 4 citations demonstrated that extended lymph node dissection may not improve biochemical recurrence rates in intermediate-to high-risk prostate cancer patients undergoing robotic-assisted radical prostatectomy—a finding that could reshape surgical guidelines. Dr. Sawada is also at the forefront of surgical innovation, having conducted the first clinical evaluations of Japan’s HINOTORI™ robotic platform against the da Vinci® system, showing comparable performance in sacrocolpopexy. His 2024 case report (1 citation) on robot-assisted nephrectomy with inferior vena cava thrombectomy following pembrolizumab-axitinib therapy highlights his expertise in combining advanced robotics with modern immunotherapy for complex renal cell carcinoma. By integrating rigorous outcomes research with cutting-edge technology assessment, Dr. Sawada is helping define the next generation of minimally invasive urologic oncology.

Research Focus

Key Achievements

2
H-Index
3
Papers
7
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Extended Lymph Node Dissection May Not Provide a Therapeutic Benefit in Patients with Intermediate-to High-Risk Prostate Cancer Treated with Robotic-Assisted Radical Prostatectomy
4 citations · 2025
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Ehime University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago